Hilton Worldwide Holdings Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Hilton Worldwide Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1657
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:97
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Hilton Worldwide Holdings Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Hilton Worldwide Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Hilton Worldwide Holdings Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Hilton Worldwide Holdings Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Hilton Worldwide Holdings Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Hilton Worldwide Holdings Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Hilton Worldwide Holdings Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Hilton Worldwide Holdings Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Hilton Worldwide Holdings Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
PARTNERSHIP 24
Partnership – Overview 24
Partnership – Deal reports 25
CAPITAL RAISING 27
Capital Raising – Overview 27
Capital Raising – Deal reports 28
DIVESTMENTS 52
Divestments – Overview 52
Divestments – Deal reports 53
PRIVATE EQUITY & OWNERSHIP 78
Private Equity and Ownership – Overview 78
Private Equity and Ownership – Deal reports 79
APPENDIX 87
Contact Us 87
About MarketLine Financial Deals Database 87
Deal Definition and Methodology 89
About MarketLine 96

List of Tables
Table 1: Hilton Worldwide Holdings Inc. M&A volume and value trend (2014-YTD2018)
Table 2: Hilton Worldwide Holdings Inc. M&A activity by geography (2014-YTD2018)
Table 3: Hilton Worldwide Holdings Inc. partnership volume and value trend (2014-YTD2018)
Table 4: Hilton Worldwide Holdings Inc. partnership trend by key deal type (2014-YTD2018)
Table 5: Hilton Worldwide Holdings Inc. capital raising volume and value trend (2014-YTD2018)
Table 6: Hilton Worldwide Holdings Inc. capital raising by deal type (2014-YTD2018)
Table 7: Hilton Worldwide Holdings Inc. divestments volume and value trend (2014-YTD2018)
Table 8: Hilton Worldwide Holdings Inc. divestments activity by geography (2014-YTD2018)
Table 9: Hilton Worldwide Holdings Inc. private equity and ownership volume and value trend (2014-YTD2018)
Table 10: Hilton Worldwide Holdings Inc. private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Hilton Worldwide Holdings Inc. M&A volume and value trend (2014-YTD2018)
Figure 2: Hilton Worldwide Holdings Inc. M&A activity by geography (2014-YTD2018)
Figure 3: Hilton Worldwide Holdings Inc. partnership volume and value trend (2014-YTD2018)
Figure 4: Hilton Worldwide Holdings Inc. partnership trend by key deal type (2014-YTD2018)
Figure 5: Hilton Worldwide Holdings Inc. capital raising volume and value trend (2014-YTD2018)
Figure 6: Hilton Worldwide Holdings Inc. capital raising by deal type (2014-YTD2018)
Figure 7: Hilton Worldwide Holdings Inc. divestments volume and value trend (2014-YTD2018)
Figure 8: Hilton Worldwide Holdings Inc. divestments by geography (2014-YTD2018)
Figure 9: Hilton Worldwide Holdings Inc. private equity and ownership volume and value trend (2014-YTD2018)
Figure 10: Hilton Worldwide Holdings Inc. private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Hilton Worldwide Holdings Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson's disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, …
  • Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment o …
  • Rallis India Ltd (RALLIS):企業の財務・戦略的SWOT分析
    Summary Rallis India Ltd (Rallis), a subsidiary of Tata Chemicals Ltd, is an agri-solutions service provider. The company’s business portfolio includes domestic crop protection, international business, contract manufacturing, seeds, plant growth nutrients and agri services. Its products portfolio in …
  • City Utilities of Springfield:企業の戦略的SWOT分析
    City Utilities of Springfield - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Brenntag AG:企業のM&A・事業提携・投資動向
    Brenntag AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brenntag AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Vertu Motors Plc:企業のM&A・事業提携・投資動向
    Vertu Motors Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vertu Motors Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Pinnacle Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia International Corp is a drug development company that develops and markets photodynamic therapy products. The company offers products such as OPTIGUIDE PI, ETHYOL PI, PHOTOFRIN PI, and DIOMED products, among others. Its O …
  • Access Bio Inc (950130):医療機器:M&Aディール及び事業提携情報
    Summary Access Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. …
  • Volt Information Sciences Inc (VOLT):企業の財務・戦略的SWOT分析
    Volt Information Sciences Inc (VOLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Biotec Pharmacon ASA (BIOTEC):企業の財務・戦略的SWOT分析
    Summary Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection …
  • Safran Nacelles Ltd :企業の戦略・SWOT・財務情報
    Safran Nacelles Ltd - Strategy, SWOT and Corporate Finance Report Summary Safran Nacelles Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Taiwan Mobile Co., Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Mobile Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Mobile Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aurora Spine Corp (ASG):企業の財務・戦略的SWOT分析
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • Airgas, Inc.:戦略・SWOT・企業財務分析
    Airgas, Inc. - Strategy, SWOT and Corporate Finance Report Summary Airgas, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報
    Summary Prestige Brands Holdings Inc (Prestige) focuses on the marketing, sales and distribution of over-the-counter (OTC) healthcare and household cleaning brands. The company offers its products for digestive care; lice treatment, household cleaning; hygiene; oral care; pain relief; pediatric care …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fred’s, Inc.:戦略・SWOT・企業財務分析
    Fred's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fred's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Torax Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TORAX Medical Inc (Torax Medical), a subsidiary of Ethicon US LLC, is a healthcare company that offers technology solutions. The company offers LINX reflux management system, a clinical stage medical device. Torax Medical offers treatment for gastro esophageal reflux disease that can turn in …
  • Immune Therapeutics Inc (IMUN):製薬・医療:M&Aディール及び事業提携情報
    Summary Immune Therapeutics Inc (IMUN), formerly pH Environmental Inc, is a specialty pharmaceutical company that discovers, develops and commercializes patented therapies and technology such as Lodonal, LDN, CAR-T and MENK. The company’s patented therapies are focused on the activation and re-balan …
  • Atkore International Group Inc (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆